EP1343813A4 - Nouveaux composes - Google Patents

Nouveaux composes

Info

Publication number
EP1343813A4
EP1343813A4 EP01991347A EP01991347A EP1343813A4 EP 1343813 A4 EP1343813 A4 EP 1343813A4 EP 01991347 A EP01991347 A EP 01991347A EP 01991347 A EP01991347 A EP 01991347A EP 1343813 A4 EP1343813 A4 EP 1343813A4
Authority
EP
European Patent Office
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01991347A
Other languages
German (de)
English (en)
Other versions
EP1343813A1 (fr
Inventor
Pankaj Agarwal
Marian Birkeland
John P Cogswell
Karen F Kabnick
Ying-Ta Lai
Shelby A Martensen
Safia K Rizvi
Randall F Smith
Jay C Strum
Qing Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Glaxo Group Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
Glaxo Group Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, Glaxo Group Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Publication of EP1343813A1 publication Critical patent/EP1343813A1/fr
Publication of EP1343813A4 publication Critical patent/EP1343813A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP01991347A 2000-12-19 2001-12-17 Nouveaux composes Withdrawn EP1343813A4 (fr)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US25671000P 2000-12-19 2000-12-19
US256710P 2000-12-19
US25704800P 2000-12-20 2000-12-20
US257048P 2000-12-20
US26048201P 2001-01-09 2001-01-09
US260482P 2001-01-09
US26492201P 2001-01-30 2001-01-30
US264922P 2001-01-30
US26679701P 2001-02-06 2001-02-06
US266797P 2001-02-06
US27698801P 2001-03-19 2001-03-19
US276988P 2001-03-19
US28153501P 2001-04-04 2001-04-04
US281535P 2001-04-04
US28962201P 2001-05-08 2001-05-08
US289622P 2001-05-08
PCT/US2001/049232 WO2002050105A1 (fr) 2000-12-19 2001-12-17 Composes

Publications (2)

Publication Number Publication Date
EP1343813A1 EP1343813A1 (fr) 2003-09-17
EP1343813A4 true EP1343813A4 (fr) 2004-11-17

Family

ID=27575289

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01991347A Withdrawn EP1343813A4 (fr) 2000-12-19 2001-12-17 Nouveaux composes

Country Status (4)

Country Link
EP (1) EP1343813A4 (fr)
JP (1) JP2004531214A (fr)
AU (1) AU2002231077A1 (fr)
WO (1) WO2002050105A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030149238A1 (en) * 2000-02-14 2003-08-07 Pankaj Agarwal Novel compounds
EP1276866A4 (fr) * 2000-03-24 2005-03-16 Smithkline Beecham Corp Nouveaux composes
US20020111302A1 (en) * 2000-11-30 2002-08-15 Y. Tom Tang Novel nucleic acids and polypeptides
US6664091B2 (en) 2000-12-18 2003-12-16 Millennium Pharmaceuticals, Inc. 53010, a human carboxylesterase family member and uses thereof
AU2002324058A1 (en) * 2001-08-21 2003-03-10 Bayer Healthcare Ag Regulation of human g protein-couple receptor kinase
AU2002357666A1 (en) * 2001-10-24 2003-05-06 Millennium Pharmaceuticals, Inc. 69583 and 85924, novel human protein kinase family members and uses therefor
WO2003046006A1 (fr) * 2001-11-27 2003-06-05 Bayer Healthcare Ag Polynucleotides codant pour l'inhibiteur d'une serine protease parente de la nexine
FR2837492B1 (fr) * 2002-03-21 2007-07-20 Commissariat Energie Atomique Transporteur apical d'iode et ses applications
AU2003226131A1 (en) 2002-03-28 2003-10-13 Bristol-Myers Squibb Company Novel human cell surface protein with immunoglobulin folds, bgs-19
WO2003104427A2 (fr) 2002-06-05 2003-12-18 Case Western Reserve University Methodes et compositions pour detecter des cancers
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
WO2005095637A1 (fr) * 2004-03-02 2005-10-13 Bayer Healthcare Ag Diagnostics et produits therapeutiques relatifs a des maladies associes a kinase 4 beta de lignee melangee (mlk4 beta)
WO2005103240A1 (fr) * 2004-04-24 2005-11-03 Bayer Healthcare Ag Agents diagnostiques et therapeutiques pour maladies associees a la caseine kinase1, delta, isoforme1 (csnk1d iso 1)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001020A2 (fr) * 1997-07-01 1999-01-14 Human Genome Sciences, Inc. 19 proteines secretees humaines
WO1999058565A1 (fr) * 1998-05-08 1999-11-18 Karolinska Innovations Ab Proteine relative a la cystatine
EP0976764A1 (fr) * 1997-04-01 2000-02-02 Chugai Research Institute for Molecular Medicine Inc. Nouvelle proteine secretee par une membrane
WO2000031264A2 (fr) * 1998-11-20 2000-06-02 Zymogenetics, Inc. Proteine cystatine t de type cystatine specifique des testicules
WO2001094388A2 (fr) * 2000-06-05 2001-12-13 Zymogenetics, Inc. Zcys6: membre de la superfamille des cystatines

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0976764A1 (fr) * 1997-04-01 2000-02-02 Chugai Research Institute for Molecular Medicine Inc. Nouvelle proteine secretee par une membrane
WO1999001020A2 (fr) * 1997-07-01 1999-01-14 Human Genome Sciences, Inc. 19 proteines secretees humaines
WO1999058565A1 (fr) * 1998-05-08 1999-11-18 Karolinska Innovations Ab Proteine relative a la cystatine
WO2000031264A2 (fr) * 1998-11-20 2000-06-02 Zymogenetics, Inc. Proteine cystatine t de type cystatine specifique des testicules
WO2001094388A2 (fr) * 2000-06-05 2001-12-13 Zymogenetics, Inc. Zcys6: membre de la superfamille des cystatines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO0250105A1 *
TOEHOENEN V ET AL: "TESTATIN: A CYSTATIN-RELATED GENE EXPRESSED DURING EARLY TESTIS DEVELOPMENT", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 95, January 1998 (1998-01-01), pages 14208 - 14213, XP000857715, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
EP1343813A1 (fr) 2003-09-17
JP2004531214A (ja) 2004-10-14
WO2002050105A1 (fr) 2002-06-27
AU2002231077A1 (en) 2002-07-01

Similar Documents

Publication Publication Date Title
AU7476301A (en) Novel compounds
EP1276755A4 (fr) Nouveaux composes
GB0003019D0 (en) Novel compounds
AU9261901A (en) Novel compounds
EP1255771A4 (fr) Nouveaux composes
GB0008464D0 (en) Novel compounds
EP1292617A4 (fr) Composes
EP1472352A4 (fr) Nouveaux composes
EP1343813A4 (fr) Nouveaux composes
AU7476401A (en) Novel compounds
EP1276866A4 (fr) Nouveaux composes
GB0004149D0 (en) Novel compounds
EP1299530A4 (fr) Nouveaux composes
GB0003636D0 (en) Novel compounds
GB0001898D0 (en) Novel compounds
GB0002402D0 (en) Novel compounds
GB0004196D0 (en) Novel compounds
EG22332A (en) Novel compounds
GB0004188D0 (en) Novel Compounds
GB0006132D0 (en) Novel compounds
GB0004071D0 (en) Novel compounds
GB0004186D0 (en) Novel Compounds
GB0003112D0 (en) Novel compounds
GB0002196D0 (en) Novel compounds
GB0004269D0 (en) Novel compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030606

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/86 B

Ipc: 7C 12N 15/85 B

Ipc: 7C 12N 15/63 B

Ipc: 7C 12N 15/00 B

Ipc: 7C 12N 1/21 B

Ipc: 7C 07K 14/00 B

Ipc: 7C 07H 21/04 B

Ipc: 7C 07H 21/02 B

Ipc: 7C 07K 14/47 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040929

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20051206